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Abstract
Psoriatic arthritis (PsA) is a chronic infl ammatory joint disease that occurs in patients with psoriasis. Typically, 
involvement of the peripheral joints (with an asymmetric pattern) and the axial skeleton can be recognized. Th ere are 
no specifi c laboratory tests for PsA and the diagnosis relies on clinical and imaging fi ndings. Conventional radiology 
and magnetic resonance are the most valuable imaging modalities, with ultrasound becoming more and more used 
due to its feasibility and high sensitivity for peripheral disease manifestations. Th e authors off er a concise overview of 
PsA, common imaging fi ndings, and literature update.
Keywords: Arthritis, psoriatic – diagnostic imaging, pathology; Diagnostic imaging – methods; Magnetic reso-
nance imaging – methods; Ultrasonography; Tomography, x-ray computed; Joints – diagnostic imaging, pathology; 
Tenosynovtis – diagnostic imaging; Enthesopathy – diagnostic imaging
Sažetak
Psorijatični artritis kronična je upalna bolest zglobova koja se javlja u pacijenata sa psorijazom. Tipično zahvaća 
periferne zglobove (s asimetričnim uzorkom) te aksijalni skelet. Ne postoje laboratorijski testovi specifi čni za psorija-
tični artritis pa dijagnostički postupak počiva na kliničkom nalazu i slikovnim pretragama. Najčešće se rabe klasične 
radiološke pretrage i magnetska rezonancija, a sve više raste i upotreba ultrazvuka zbog njegove jednostavnosti i viso-
ke osjetljivosti za periferne pokazatelje bolesti. Autori donose sažeti pregled psorijatičnog artritisa, tipičnih nalaza sli-
kovnih metoda i novosti iz literature.
Ključne riječi: Psorijatični arthritis – dijagnostički prikaz, patologija; Diagnostički prikaz – metode; Magnetska 
rezonancija – metode; Ultrazvuk; Kompjutorizirana tomografi ja; Zglobovi – dijagnostički prikaz, patologija; Tenosi-
novitis – dijagnostički prikaz; Entezopatija – dijagnostički prikaz
Introduction
Psoriatic arthritis (PsA) is a chronic infl ammatory 
arthropathy occurring in 6% to 48% of the patients 
with skin psoriasis (1, 2, 3), typically presenting with 
arthritis, enthesitis, and/or dactylitis, while the skin 
symptoms may be subtle (4). Evidence suggests that 
the underlying pathology includes both genetic and 
environmental factors that cause profuse proinfl am-
matory processes in the skin and synovium, involving 
tumor necrosis factor (TNF)-α, interleukin (IL)-1β, 
IL-6, IL-13, and nuclear factor-κ β ligand, which fi nally 
leads to osteoclast-driven destruction of the joint (3, 
5). Although there are some similarities with rheuma-
toid arthritis (RA), PsA is oft en seronegative for rheu-
matoid factor, and, on closer inspection, diff erent clin-
ical and imaging patterns are evident (4, 6). Th e disease 
typically begins as enthesitis of articular capsules, fas-
ciae, tendons, and ligaments. Typically, involvement of 
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the peripheral joints (with an asymmetric pattern) and 
the axial skeleton can be recognized (7). Based on the 
clinical presentation, fi ve patterns of PsA have been de-
scribed by Moll and Wright (1):
(a) asymmetric oligoarticular or monoarticular ar-
thritis primarily aff ecting the distal interphalangeal 
(DIP), proximal interphalangeal (PIP), and metatar-
sophalangeal joints; (b) DIP-predominant arthritis; (c) 
arthritis mutilans; (d) symmetric, rheumatoid factor 
(RF)-negative polyarthritis; and (e) psoriatic spondy-
loarthropathy. As there are no specifi c laboratory tests 
for PsA, the diagnosis is mainly based on the clinical 
presentation and imaging fi ndings (3). Based on a 
study involving 588 patients with PsA and 536 control 
subjects, the Classifi cation of Psoriatic Arthritis (CAS-
PAR) study group has formulated criteria for the diag-
nosis of PsA: the presence of psoriasis or a family his-
tory of psoriasis, dactylitis, juxta-articular new bone 
formation, negative RF, and nail dystrophy (8). If three 
of the above-mentioned criteria are met, there is a 
strong indication of PsA.
Methods
A computerized literature search, from January 1, 
2015 to May 31, 2017, was conducted by the authors to 
identify articles on imaging in patients with PsA. Arti-
cles were retrieved through PubMed search using the 
US National Library Medical Subject Headings (MeSH) 
term “Arthritis, Psoriatic/diagnostic imaging”. Publica-
tions both in English and in German were considered. 
Reviews, editorials, case reports, letters, and commen-
taries were excluded. Th e search yielded a total of 60 
articles and aft er an abstract review, 32 were found eli-
gible and retrieved as full-text articles. Some articles 
were excluded due to having been electronically pub-
lished on an earlier date. A total of 24 articles fulfi lling 
all inclusion criteria were included in the study.
Results
Imaging methods
Various imaging methods are used in patients with 
suspected or established PsA, mainly conventional ra-
diography (CR), ultrasonography (US), and magnetic 
resonance imaging (MRI) (4, 9). Computed tomogra-
phy (CT) is the gold standard for assessment of bone 
structure, but is only used in exceptional cases of arth-
ritides due to ionizing radiation (4, 7, 10). Other imag-
ing modalities, i.e., scintigraphy, positron emission to-
mography (PET), single photon emission CT, and du-
al-emission x-ray absorptiometry, are seldom used in 
PsA (4, 7).
Conventional radiography
CR remains the most widely used imaging tech-
nique, off ering high spatial resolution, and fast, relia-
ble, and relatively inexpensive imaging of the bone 
structure (4). It is not as sensitive in the detection of 
erosive lesions as CT, but it has a high specifi city (11). 
Th e main drawback is the 2-D visualization of a 3-D 
structure, resulting in suboptimal delineation of bone, 
especially in complex joints (4). Imaging includes AP 
and lateral views of painful joints, as well as AP and 
lateral views of hands and feet for evaluation of the 
structural changes in DIP joints, which can oft en show 
typical radiographic signs, even if the joint is asympto-
matic (3, 10). Evaluation of the axial skeleton for atypi-
cal syndesmophytes is also recommended, but since 
higher radiation doses are involved, MRI has recently 
become the more favoured modality in spine assess-
ment (4, 12). Th e characteristics of a bone lesion seen 
in PsA result from a combination of erosive and prolif-
erative bone changes: a large, poorly demarcated ero-
sion of the bony cortex in a para-articular site is oft en 
seen, closely associated with new bone formation (3, 
6). Typical fi ndings include opera-glass deformity (tel-
escoping erosive joint destruction), fl uff y periostitis 
due to periosteal ossifi cation; pencil-in-cup deformity 
consisting of destruction of the head of the middle and 
expansion of the base of the distal phalanx, and ac-
roosteolysis – resorption of the tuft  of the distal pha-
lanx (Figures 1 and 2). In patients with axial disease, 
sacroiliitis, syndesmophytes, paravertebral ossifi ca-
tion, and destructive discovertebral lesions can be 
found (3, 10). Early diagnosis is of utmost importance, 
and Haroon et al. have shown that even a 6-month de-
lay from symptom onset to the fi rst visit with a rheu-
matologist contributes to the development of periph-
eral joint erosions and worse long-term physical func-
tion (13). Unfortunately, CR reveals infl ammatory 
changes in peripheral joints months or years aft er the 
onset of clinical symptoms (10, 14).
Semi-quantitative scoring methods originally devel-
oped for rheumatoid arthritis, designed to measure the 
degree of radiographically detectable joint damage and 
changes over time, have been adopted for the use in 
PsA and described by Wassenberg (15). A novel scor-
ing method called Reductive X-ray Score for Psoriatic 
Arthritis has been proposed by Tillet et al (16). Th e 
method is sensitive to change and includes three hall-
mark features of PsA: erosion, joint space narrowing 
(JSN), and osteoproliferation. Fewer joints need to be 
assessed than in using the most common and most fea-
sible score, PsA-modifi ed Steinbrocker, while the 
method maintains a similar sensitivity to change as the 
Sharp/van der Heijde (SvdH) score, which is currently 
the most sensitive method developed.
Geijer et al. (17) obtained hand and foot radiographs 
for 72 of 197 PsA patients enrolled in the Swedish pso-
riatic arthritis registry and followed for 5 years. Radio-
graphic progression in early PsA was generally slow 
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but substantial. Male sex appeared to be a risk factor 
for early radiographic damage while the presence of 
baseline radiographic damage and dactylitis develop-
ing during follow-up could predict further destruc-
tion.
Jadon et al. reported on diff erences between clinical 
characteristics of patients with PsA with PsA mutilans 
(PAM) and without PAM (18). In a retrospective co-
hort study including 610 patients (36 of who had 
PAM), PAM cases were diagnosed with PsA at an ear-
lier age, had poorer function, more prevalent nail dys-
trophy, and more severe radiographic axial disease/
sacroiliitis. Th e rate of osteolysis was higher in earlier 
disease, and more severe in those with nail dystrophy.
Kavanaugh et al. (19) reported results from a rand-
omized, placebo‐controlled phase III trial that evalu-
ated clinical effi  cacy and radiographic benefi t through 
two years of ustekinumab therapy in patients with ac-
tive PsA. A total of 615 adult patients with PsA were 
enrolled and radiographic progression was scored us-
ing the modifi ed SvdH score with modifi cations for 
PsA. Th e results showed that mean changes were nu-
merically lower in the ustekinumab groups than in the 
placebo crossover group.
Kavanaugh et al. recently published another paper 
(20) on evaluation of long‐term outcomes in 395 PsA 
patients who achieved or did not achieve minimal dis-
ease activity (MDA) through 5 years of golimumab 
treatment in the GO‐REVEAL trial. Golimumab treat-
ment yielded signifi cantly higher MDA response rates 
versus patients randomized to placebo, and achieve-
ment of MDA at ≥3 and ≥4 consecutive visits was as-
sociated with signifi cantly less radiographic progres-
sion (measured by SvdH score).
Jadon et al. also reported on prevalence as well as 
clinical and radiographic characteristics of psoriatic 
spondyloarthritis (PsSpA) in PsA with ankylosing 
spondylitis (AS) (21). In a combined cohort of 201 pa-
tients with PsA and 201 patients with AS from a single 
centre, 24% fulfi lled the classifi cation criteria for both 
conditions. Th e pattern of axial disease was signifi cant-
ly infl uenced by the presence of skin psoriasis and 
HLA-B*27.
In a recent study on 45 PsA patients (22) CR was 
used to establish an association between nail psoriasis 
and DIP involvement. Th e results showed that a sig-
nifi cant proportion of PsA patients had nail involve-
ment and DIP arthritis.
Haroon et al. conducted a study on axial involve-
ment (23), aiming to identify clinical and genetic as-
Figure 1 Conventional AP radiographs of the hands of an 
85-year-old male patient with PsA. Note the narrowing of the 
interphalangeal joint spaces with osteophytosis and sclerosis 
– classic signs of osteoarthritic changes (white arrows). Fluff y 
bone appearance is seen at the site of active disease (asterisk). 
Erosion of the heads of the proximal phalanges results in the 
“pencil-in-cup” sign (black arrows). Subluxation of the fi rst 
MCP joint can also be seen (white arrowhead). Typically of 
PsA, changes are asymmetric and seen in the distal joints.
Slika 1. Standardne rendgenske snimke obiju šaka 
85-godišnjega muškog pacijenta sa PsA učinjene u AP projekciji. 
Vidljivo je suženje interfalangealnih zglobnih prostora s 
osteofi tozom i sklerozacijom zglobnih tijela – tipični znakovi 
osteoartritičkih promjena (bijele strjelice). Kost na mjestu 
aktivne bolesti ima „čupav” izgled (zvjezdica). Erozija glava 
proksimalnih falangi dovodi do pojave znaka „olovke u šalici” 
(crne strjelice). Također je vidljiva subluksacija prvog MCP 
zgloba (bijeli vrh strjelice). Uobičajeno za PsA, promjene su 
asimetrične i zahvaćaju distalne zglobove.
Figure 2 Conventional AP radiographs of the feet of an 
85-year-old male patient with PsA. Erosion of the head of the 
proximal phalanx resulting in the “pencil-in-cup” sign is seen 
in the right big toe (black arrowhead). Some soft  tissue 
swelling is also present.
Slika 2. Standardne rendgenske snimke obaju stopala 
85-godišnjeg muškog pacijenta sa PsA učinjene u AP projekciji. 
Vidljiva je erozija glave proksimalne falange palca desnog 
stopala koja uzrokuje znak „olovke u šalici“ (crni vrh strjelice). 
Prisutan je i edem mekih česti.
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sociations of sacroiliitis (SI) in patients with PsA, and 
to describe the radiographic patterns of SI in PsA. Th e 
study showed that early onset of PsA, severe skin dis-
ease, peripheral joint erosions, and HLA-B*0801 are 
signifi cantly associated with SI, whereas HLA-B*2705 
only showed marginal signifi cance. In this study, HLA-
B*27 positive Axial-PsA patients resembled AS, while 
HLA-B*0801 positive Axial-PsA patients had asym-
metrical and/or unilateral SI, typical of PsA.
Computed tomography
While CT off ers excellent imaging of bone structures 
and is considered to be the “gold standard” in the eval-
uation of bone, this modality is still not able to detect 
active infl ammation sites. Besides, there is the issue of 
the ionizing radiation exposure limit applicability of 
CT in routine diagnosis and management of PsA (4, 7, 
10). Findings of micro-CT scans of peripheral joints in 
PsA patients include Ω-shaped erosions in the meta-
carpophalangeal joints (24), and new bone formation 
at entheses can be detected in both psoriasis patients 
without arthritis and PsA patients (25, 26). Regarding 
the assessment of the axial skeleton, although CT of 
the SI joints can give a satisfactory display of bone ero-
sion, sclerosis, and joint space alterations including an-
kylosis, MRI is the preferred technique. In the assess-
ment of the spine, CT is mainly used when vertebral 
fracture is suspected in PsA patients (4, 12).
A study by Kocijan et al. (27) evaluated bone micro-
structure and volumetric bone mineral density (BMD) 
in patients with PsA and psoriasis using high-resolu-
tion peripheral quantitative CT (HR-pQCT) scans at 
the ultradistal and periarticular radius. Th e study en-
rolled 50 PsA patients, 30 psoriasis patients, and 70 
healthy, age- and sex-related controls. Th e results sug-
gest that PsA is associated with signifi cantly decreased 
trabecular volumetric BMD and deterioration of tra-
becular bone microstructure. Th e cortical BMD and 
microstructure in PsA patients didn’t diff er from the 
control group, in contrast with current fi ndings in RA. 
Also, the duration of skin disease was associated with 
trabecular bone loss in PsA patients, a fi nding support-
ing the concept of subclinical musculoskeletal disease 
in psoriasis patients.
Magnetic resonance
MRI allows high-resolution imaging of all structures 
involved in arthritis, and is sensitive for peripheral and 
axial disease manifestations (4). Today, all joints can be 
evaluated with similar effi  cacy, and the technique is 
suffi  ciently standardized (7). Dynamic contrast-en-
hanced MRI in combination with current soft ware of-
fers acquisition of quantitative data about infl amma-
tory processes, such as: ME (maximum enhancement), 
IRE (initial rate of enhancement), GD (gadolinium) 
distribution, and Tonset (time of onset) that can be 
coded in color maps for further analysis (28).
For peripheral disease, T1-weighted sequences in 2 
planes supplemented by a T2-weighted, fat-suppressed, 
or short tau inversion recovery sequences are generally 
performed to visualize synovitis, enthesitis, tenosyno-
vitis, periarticular infl ammation, bone marrow edema, 
bone erosion, and bone proliferation. Additional T1-
weighted sequences aft er intravenous injection of a 
gadolinium contrast agent can aid identifi cation of in-
fl amed tissue (4, 29, 30). MRI can aid in diff erential 
diagnosis between PsA, RA, and OA. Bone marrow 
edema in PsA is frequently found close to the entheses, 
while in RA it is located near the capsular attachments, 
and in OA closer to subchondral areas (4, 31). Bone 
erosions are commonly located adjacent to collateral 
ligament insertions in PsA, and in OA they tend to 
have a central location (4, 32). Periostitis has been 
shown to be more frequent in PsA, while bone erosions 
are more common in RA (4, 33). Bone marrow edema 
and/or enthesitis in diaphyses are much more common 
in PsA than in RA (4, 34).
Th ere are no specifi c defi nitions for MRI assessment 
of axial PsA, but defi nitions regarding SpA are available 
(35, 36). Th e main lesions assessed are bone marrow 
edema/osteitis, enthesitis, fat infi ltration, bone erosion, 
bone proliferation, and ankylosis. Regarding the spine, 
bone marrow edema or soft  tissue edema/enthesitis, are 
commonly seen at the anterior and posterior corners of 
the vertebral bodies, and at the costovertebral, facet, 
and costotransverse joints, while erosive discovertebral 
lesions (Andersson lesions) are less frequent but can be 
the fi rst sign of the disease (4, 37).
Yanaba et al. (38) used the PsA MRI scoring system 
(PsAMRIS) (30) to evaluate the eff ects of adalimumab 
treatment in fi ve adult Japanese male patients with ac-
tive PsA. Th e study indicated that adalimumab treat-
ment is associated with a dramatic improvement of 
enthesitis, whereas bone erosions may be resistant to 
such treatment.
Zubler et al. (39) compared MRI fi ndings of the fore-
feet in 31 healthy volunteers, 30 patients with sympto-
matic RA, and 30 patients with symptomatic PsA, to 
identify MRI patterns of RA or PsA. Mild bone mar-
row edema was a common fi nding, and tenosynovitis 
and joint eff usion were occasional fi ndings in healthy 
volunteers. Tenosynovitis and soft -tissue edema were 
more frequently observed in patients with PsA, while 
other arthritis-like fi ndings on MRI were similar in pa-
tients with RA and PsA.
Ultrasound
Ultrasound (US) provides feasible, high-resolution 
visualization of all structures involved in peripheral ar-
thritis, and is sensitive for peripheral disease manifes-
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tations, but is not recommended for the assessment of 
axial involvement (4). Th e current European League 
Against Rheumatism (EULAR) recommendations on 
the use of imaging techniques encourage the use of US 
in chronic arthridides (12, 40), and over recent years 
research has proved US to be valid, sensitive, and reli-
able in the assessment of synovitis, tenosynovitis, and 
enthesitis, including anatomical damage (bone and/or 
tendon erosions) in patients with RA or PsA (Figure 
3). Moreover, there are also promising results regard-
ing its prognostic value (41, 42). Because an US wave 
cannot penetrate bones, the technique is less sensitive 
than MRI and CT for diagnosing bone erosions and 
unable to diagnose osteitis (4). US fi ndings in clinical 
or subclinical synovitis are nonspecifi c and the diag-
nostic value lies in recognizing the joint infl ammation 
(4, 12). US diagnosis of enthesitis has received a lot of 
scientifi c attention lately. Th e hallmark lesions of en-
thesitis are (a) chronic changes: presence of entheso-
phytes, calcifi cations, and erosions at the insertion site 
and (b) infl ammatory changes: increased thickness, 
hypoechogenicity, and Doppler activity in the enthesis 
(4, 43). An example of US imaging in PsA is shown in 
Figure 3.
Acquacalda et al. conducted a study on the preva-
lence of ultrasonographic enthesitis in psoriasis pa-
tients with or without musculoskeletal symptoms (44). 
Data were obtained from 340 entheses in 34 patients. 
At baseline, US abnormalities were found in 97.1% of 
the total population and in 86.4% of the asymptomatic 
patients. At 6 months under systemic treatment, US 
morphological abnormalities were likely to improve.
Lin et al. (45) aimed to compare high-frequency ul-
trasound (HFU) fi ndings in the fi ngers with PsA and 
RA and to explore the potential use of HFU in the ear-
ly diagnosis of PsA. Th e study enrolled 44 PsA and 39 
RA patients, and 20 healthy individuals. Th e results 
suggested that HFU is valuable in the detection of soft  
tissue infl ammation and enthesitis in the fi ngers of PsA 
patients, and that it may be an easy, safe, and eff ective 
examination method in the early diagnosis of PsA as 
well as in the observation of related pathological 
changes.
Michelsen et al. conducted a cross-sectional study 
involving 141 PsA outpatients to investigate the asso-
ciation between clinical and ultrasonographic (US) 
evidence of infl ammation in psoriatic arthritis (PsA), 
as well as to compare clinical and US remission criteria 
(46). Th e Disease Activity Index for PSoriatic Arthritis 
(DAPSA) and 28-joint Disease Activity Score (DAS28) 
refl ected US fi ndings better than the Composite Psori-
Figure 3 US imaging of the 
interphalangeal joints in the hand of 
an 85-year-old male patient with 
PsA. Longitudinal scan (a) and 
transversal scan (b) show 
periarticular calcifi cations, some 
osteophytes (asterisks), and soft  
tissue swelling. Power-Doppler scan 
verifi es increased vascularization in 
the extensor tendon (white arrow) 
and synovial membrane 
(black arrow).
Slika 3. UZ pregled interfalangealnih 
zglobova šake stopala 85-godišnjega 
muškog pacijenta sa PsA. Uzdužni (a) 
i poprečni (b) prikaz pokazuju 
periartikularne kalcifi kacije i nekoliko 
osteofi ta (zvjezdice) te edem mekih 
česti. Prikaz Power Dopplerom 
potvrđuje pojačanu vaskularizaciju u 
području tetive ekstenzora (bijela 
strjelica) i u sinovijskoj membrani 
(crna strjelica).
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atic Disease Activity Index (CPDAI) and Psoriatic Ar-
thritiS Disease Activity Score (PASDAS). MDA was 
fulfi lled in 22.7% and the clinical remission criteria in 
5.7%–9.9% of the patients. US remission (no Power 
Doppler activity in all examined joints, enthuses, and 
tendons) was found in 49.6% of the patients. Minimal 
disease activity (MDA), DAPSA, and Boolean’s remis-
sion criteria predicted US remission.
Fiocco et al. have recently investigated contrast-en-
hanced US (CEUS) imaging with histopathological 
and immunohistochemical quantitative estimation of 
microvascular proliferation on synovial samples of pa-
tients aff ected by PsA (47) and investigated a possible 
association with the frequencies of pathogenic T help-
er (Th )-17 cells in PsA joints in eight patients (48). Th e 
results indicate that CEUS can truly measure synovial 
infl ammation, and could be a useful tool to develop a 
quantitative imaging biomarker for monitoring target 
therapeutics in PsA.
Cozzi et al. (49) used CEUS to to assess synovial in-
fl ammation in hand joints and evaluate the eff ects of 
mud-bath therapy on the clinical picture of PsA pa-
tients treated with TNF inhibitors. Th eir results sug-
gest a decrease of residual synovial infl ammation and a 
benefi cial clinical eff ect of spa therapy in PsA patients 
treated with TNF inhibitors.
A study by Bandinelli et al. (50) has shown that US 
abnormalities of the hand and wrist were independent 
of early clinical PsA indices (except erosions), while 
they correlated to dermatological (except PASI), sero-
logical, and genetic parameters of disease.
Janta et al. (51) compared clinical and musculoskel-
etal (MS) US features between PsA patients treated 
with full and tapered dosages of biologic (b) disease-
modifying antirheumatic drugs (DMARDs). Th e sec-
ondary objective was to compare clinical and MSUS 
features between PsA patients treated with bDMARDs 
with and without concomitant synthetic (s) DMARDs. 
Th e presence of B-mode and Doppler synovitis, teno-
synovitis, enthesopathy, and paratenonitis was investi-
gated. No signifi cant diff erences were found between 
clinical, laboratory, and US variables, both for BM and 
CD, between patients with full and tapered dosages 
and between patients with and without concomitant 
sDMARD. Clinical assessment, MSUS variables, and 
MDA status are similar in patients receiving full and 
tapered dosages of bDMARDs.
Batmaz et al. (52) compared the femoral cartilage 
thickness of 33 PsA patients with that of 31 healthy 
controls. Th e results were similar between the two 
groups. In PsA patients the cartilage thickness was as-
sociated with disease activity, functional inadequacy, 
and enthesopathy scores.
Højgaard et al. (53) published a study protocol, aim-
ing to investigate the association and prognostic value 
of pain mechanisms, ultrasonic activity, and clinical 
outcomes in PsA patients on intensifi ed antirheumatic 
treatment.
Other modalities
Other modalities, such as PET-CT and scintigraphy, 
are rarely used in clinical practice, but are an impor-
tant focus of clinical research. Th e authors have found 
articles on use of PET-CT in the detection of asympto-
matic enthesitis in psoriasis patients, which could be a 
prognostic factor of the onset of psoriatic arthritis (54). 
Another group investigated the role of PET-CT in the 
assessment of disease activity in PsA and RA (55). A 
group of authors from Italy off ered a novel approach to 
the assessment of peripheral PsA, using functional in-
frared imaging (fIRI) with promising results (56).
Conclusion
PsA is an infl ammatory joint disease that is similar 
to RA but can be easily distinguished from it upon a 
closer inspection. It usually shows a specifi c pattern of 
joint involvement: peripheral joints with an asymmet-
ric pattern and the axial skeleton are most commonly 
aff ected. Th e clinical diagnosis relies heavily on imag-
ing fi ndings. Typical fi ndings result from a combina-
tion of erosive and proliferative bone changes and in-
fl ammatory changes in the synovia, tendons, and en-
theses. Various imaging methods have a role in PsA 
diagnosis, but CR and US are mostly used due to their 
feasibility and relatively low cost. Th ere is an increasing 
interest among researchers in the investigation of new 
possibilities in PsA diagnosis and follow-up of patients 
using both conventional US and CEUS.
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